FDA Approves Darolutamide for Metastatic Castration-Sensitive Prostate Cancer By Ogkologos - June 27, 2025 476 0 Facebook Twitter Google+ Pinterest WhatsApp Evidence for efficacy is based on the results from the ARANOTE study Source RELATED ARTICLESMORE FROM AUTHOR FDA Approves Allogeneic Regulatory T Cell-Based Immunotherapy with HSPC and T Cells-vldq for Use in Matched Donor HSCT for Adult Patients with Haematologic Malignancies Combination of mFOLFOX6/Bevacizumab Plus Atezolizumab Prolongs PFS Compared with Atezolizumab in First-Line Treatment of dMMR/MSI-H mCRC Use of YEARS Algorithm, D-dimer Levels, and Performing Risk-Dependent CT Pulmonary Angiography is Safe in Patients with Cancer and Suspected Pulmonary Embolism MOST POPULAR First Study to Demonstrate that PD1 Immune Checkpoint Blockade May Yield... December 4, 2023 Remembering With Gratitude January 7, 2021 5-Year-Old Boy Surprised With Paycheck For Helping Electrical Company Fix His... January 21, 2022 Researchers Find a Way to Prevent Cancer Cells from Taking in... July 14, 2020 Load more HOT NEWS Medical Cannabis Formulation May Be Capable of Killing Breast Cancer Cells,... Cancer Research UK honours Her Majesty The Queen, the charity’s Patron Teacher on Leave for Breast Cancer Treatment Forced to Pay for... EMA Recommends Granting a Conditional Marketing Authorisation for Dostarlimab
